Inactivation of duck hepatitis B virus by a hydrogen peroxide gas plasma sterilization system: laboratory and 'in use' testing.

Human hepatitis B virus (HBV) is an important cause of nosocomial infections and can be transmitted by contaminated instruments. However, tests of the efficacy of sterilization of materials and equipment contaminated by HBV are difficult to perform because the virus cannot be cultured in the laboratory. In this study, we aimed to evaluate the capability of a low temperature, hydrogen peroxide gas plasma sterilizer (Sterrad, Advanced Sterilization Products, Irvine California,) to inactivate duck hepatitis B virus (DHBV). In laboratory efficacy studies using DHBV dried on to glass filter carriers and exposed to one-half of the hydrogen peroxide gas plasma sterilization process, there was a 10(7) or greater decrease in the viral titer, with no infectivity detected on the carriers after treatment. In-use studies were performed using a laparoscope that was experimentally contaminated with DHBV to mimic the possible transmission of infection between successive patients. Following exposure to the hydrogen peroxide gas plasma sterilization process no transmission of DHBV infection from the laparoscope occurred despite obvious visual soiling with blood (N = 8) while the transmission rate for the unprocessed laparoscope (positive control) was 100% (26/26), and that for instruments after a water wash was 63% (7/11). In conclusion the hydrogen gas plasma sterilization process completely inactivates DHBV a representative of the hepadna group of viruses.

[1]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[2]  G. Ayliffe Control of hospital infection : a practical handbook , 1975 .

[3]  Y. Cossart,et al.  Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity , 1991, Epidemiology and Infection.

[4]  K. Tsiquaye,et al.  Chemical disinfection of duck hepatitis B virus: a model for inactivation of infectivity of hepatitis B virus. , 1993, The Journal of antimicrobial chemotherapy.

[5]  E. Muchmore,et al.  Methodological approaches to disinfection of human hepatitis B virus , 1993, Journal of clinical microbiology.

[6]  A. Haverich,et al.  Nosocomial hepatitis B virus infections in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy. , 1994, The Journal of hospital infection.

[7]  C. Scully,et al.  Gnashings of HIV , 1994, The Lancet.

[8]  S. Shalaby,et al.  Irradiation of Polymers: Fundamentals and Technological Applications , 1996 .

[9]  P. T. Jacobs,et al.  Gas-Plasma Sterilization , 1996 .

[10]  Y. Cossart,et al.  Establishment of an in-use testing method for evaluating disinfection of surgical instruments using the duck hepatitis B model. , 1996, The Journal of hospital infection.

[11]  J. Cherry,et al.  Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. , 1996, The New England journal of medicine.

[12]  M. Martell,et al.  Transmission of hepatitis C virus by a cardiac surgeon. , 1996, The New England journal of medicine.

[13]  C. Roberts,et al.  Inactivation of human immunodeficiency virus type 1, hepatitis A virus, respiratory syncytial virus, vaccinia virus, herpes simplex virus type 1, and poliovirus type 2 by hydrogen peroxide gas plasma sterilization. , 1998, American journal of infection control.

[14]  G. Ayliffe,et al.  Control of Hospital Infection , 1998, Springer US.